FDA rejects BioMarin's muscle-wasting disorder drug

(Reuters) - BioMarin Pharmaceutical Inc said on Thursday the U.S. Food and Drug Administration had rejected its drug to treat a rare muscle-wasting disorder.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro